Purchase Order HHSN272201000409P
Award Date 3/23/10
Potential Completion Date 4/30/10
Potential Value $458K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $10,394.80. The award is for laboratory equipment and supplies, with no set-aside designation. Illumina, a manufacturer of genomic sequencing and analysis instruments and reagents, has provided a range of sequencing systems and supporting products to various federal agencies through past prime...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The $52,300 award is for the provision of a Genome Analyzer instrument and related service agreement, with a period of performance ending on April 10, 2015. There was no set-aside designation for this contract. Illumina has a history of providing...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for the provision of biomaterials. The total ceiling value of the contract is $5,461.48. This award does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, has previously supported various federal agencies like the NIH, Centers for Disease Control and...
- This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for laboratory equipment and supplies. The contract has a ceiling value of $7,673.09 and a final completion date of August 31, 2015. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract provides for Illumina to supply a range of...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $5,636.16 contract is for the delivery of Illumina's sequencing systems, reagents, and services to support genomic research and analysis. Illumina, a manufacturer of genetic analysis instruments and consumables, has previously been awarded prime contracts and sub-awards across various federal agencies...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract provides for the delivery of a Solexa Genome Analyzer IX and Cluster Station with a total ceiling value of $57,758.00. This equipment supports NIAID's genomic research and analysis capabilities. The award does not have a...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $3,161.60 and is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic applications. The contract does not have a set-aside designation. Based on Illumina's history...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $3,409.10 contract is for the provision of sequencing systems, reagents, consumables, and related support services to support genomic research and diagnostics. Illumina has a history of prior prime federal contract and...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc. for $5,552.00. The award is not associated with a set-aside program. Illumina, a manufacturer of genetic sequencing systems and reagents, has provided similar products and services to support genomic sequencing and analysis for research and diagnostics across multiple federal agencies in the past. This...